Skip to content
Pharma Observatory a Scientist.com platform

Clinical trial

Fludarabine Versus Fludarabine Plus Cyclophosphamide in First Line Therapy of Younger Patients (Up to 65 Years) With Advanced Chronic Lymphocytic Leukemia (CLL)

NCT00276848 is registered in ClinicalTrials.gov with German CLL Study Group as lead sponsor.

NCT NCT00276848
Email me this page as a PDF

Search trials, sites, companies and investigators, and follow each one to the others. Individual plan, $249/seat/mo. Card required.

Get the NCT00276848 report as a PDF

The PDF carries up to 50 rows of each section, where the page shows the first few, with the sources listed. Enter a work email and confirm it from the message we send, and the report follows by email.

Registry record

As filed in ClinicalTrials.gov.

Title
Fludarabine Versus Fludarabine Plus Cyclophosphamide in First Line Therapy of Younger Patients (Up to 65 Years) With Advanced Chronic Lymphocytic Leukemia (CLL)
Lead sponsor
German CLL Study Group
Phase
Phase 3
Overall status
Completed
Start date
July 31, 1999
Completion date
July 31, 2007
Enrollment
375 (actual)
Sites
135

Conditions

As the registry lists them; a condition with its own page is linked.

chronic lymphocytic leukemia